Relationship between circulating vascular endothelial growth factor and its soluble receptor in patients with hemorrhagic fever with renal syndrome

Emerging Microbes & Infections
Emil PalTatjana Avsic-Zupanc

Abstract

Hemorrhagic fever with renal syndrome (HFRS) is characterized by endothelial dysfunction with capillary leakage without obvious cytopathology in the capillary endothelium. The aim of the study was to analyze the kinetics of vascular endothelial growth factor (VEGF) and its soluble receptor (sVEGFR-2) in HFRS patients infected with Dobrava (DOBV) or Puumala virus (PUUV). VEGF and sVEGFR-2 levels were measured in daily plasma and urine samples of 73 patients with HFRS (58 with PUUV, 15 with DOBV) and evaluated in relation to clinical and laboratory variables. In comparison with the healthy controls, initial samples (obtained in the first week of illness) from patients with HFRS had higher plasma and urine VEGF levels, whereas sVEGFR-2 levels were lower in plasma but higher in urine. VEGF levels did not differ in relation to hantavirus species, viral load, or the severity of HFRS. The comparison of VEGF dynamics in plasma and urine showed the pronounced secretion of VEGF in urine. Significant correlations were found between daily VEGF/sVEGFR-2 levels and platelet counts, as well as with diuresis: the correlations were positive for plasma VEGF/sVEGFR-2 levels and negative for urine levels. In addition, patients with hemorrhagic man...Continue Reading

References

Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·I N GavrilovskayaE R Mackow
May 29, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·T Avsic-ZupancA Lundkvist
Nov 16, 2001·Microbes and Infection·D H KrügerA Lundkvist A
May 20, 2004·Kidney International·Bieke F SchrijversAn S De Vriese
Jan 25, 2006·Experimental Cell Research·Harold F Dvorak
Feb 14, 2008·The Journal of Infectious Diseases·Ana SaksidaTatjana Avsic-Zupanc
Dec 8, 2009·Thrombosis and Haemostasis·Erich R Mackow, Irina N Gavrilovskaya
Apr 20, 2010·Cardiovascular Research·David O Bates
Dec 24, 2010·Journal of Virology·Elena E GorbunovaErich R Mackow
May 25, 2011·BMC Infectious Diseases·Ana SaksidaTatjana Avšič-Županc
Apr 12, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M KorvaT Avšič-Županc
May 15, 2013·Virulence·Andrea V Page, W Conrad Liles
Jun 8, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L PetterssonC Ahlm
Sep 11, 2013·Nature Reviews. Microbiology·Antti VaheriJukka Mustonen
Dec 18, 2013·Viruses·Katerina Tsergouli, Anna Papa
Jan 15, 2014·Virus Research·Ellen Krautkrämer, Martin Zeier
Jan 30, 2014·Virus Research·Tatjana Avšič ŽupancAlemka Markotić
Apr 23, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T Avšič-ŽupancM Korva
Jan 8, 2015·Frontiers in Microbiology·Jussi HepojokiTomas Strandin
Mar 4, 2015·Open Forum Infectious Diseases·Anne-Marie Connolly-AndersenClas Ahlm

❮ Previous
Next ❯

Citations

Feb 23, 2020·Frontiers in Microbiology·Rongrong LiuXingan Wu

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

Milliplex Analyst
LOESS
Xponent
R package nlme

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.